Speculation arises that COVID-19 vaccinations will become a permanent annual or even quarterly requirement, mirroring the business cycles of pharmaceutical companies. Germany's new vaccine passport system, which requires a booster every three months to maintain "up-to-date" status, is cited as a precursor to this global trend.


